Filed: 5/1/2026ACC: 0001999371-26-009738
📋 What this filing means
WILDCAT CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $106.18M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$106.18M
Total AUM (reported)
30.98M
Total Shares
Allocation by class
COM$106.18M100.0%
Portfolio Concentration
Top 3$106.18M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 30.98M
Sole
Full voting authority
30.98M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
FRONTIER GROUP HLDGS INC
SOLEShares28.06M
TypeSH
Market value$99.06M
93.29%
Sole
28.06M
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares2.92M
TypeSH
Market value$7.13M
6.71%
Sole
2.92M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
FRONTIER GROUP HLDGS INCSOLE | COM | 28.06M | SH | $99.06M 93.29% | 28.06M | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 2.92M | SH | $7.13M 6.71% | 2.92M | 0.00 | 0.00 |